Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Med. 2007 Feb;120(2 Suppl 1):S9-17; discussion S29-32.

The endocannabinoid system: mechanisms behind metabolic homeostasis and imbalance.

Author information

  • Obesity Research Center, University of Cincinnati, 231 Albert Sabin Way, Room G-059, Cincinnati, Ohio, 45267, USA. steve.woods@psychiatry.uc.edu

Abstract

Scientific interest in the endocannabinoid (EC) system developed as a result of the known effects of tetrahydrocannabinol, including an increased desire to consume food. Further investigation has led to the belief that the EC system plays a role in accumulation of intra-abdominal fat and worsening of cardiovascular disease (CVD) risk factors. The EC system has been identified as a neuromodulatory system that is normally inactive but can be overstimulated to cause and exacerbate numerous metabolic pathologies. EC agonists and receptors have been identified in the brain, liver, and peripheral adipose tissue, and the EC system is known to affect metabolism in these areas and others through neuromodulatory signals. Meal size, body weight, and numerous metabolic factors such as triglyceride and cholesterol levels, insulin resistance, and glucose intolerance can be affected via the EC system. Further research into the EC system is warranted to elucidate its role in metabolic homeostasis.

PMID:
17296344
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk